SPOP and prostate carcinoma: As expected, depletion of SPOP or expression of an F133V mutant suppressed HDR and instead enhanced NHEJ after introduction of DSBs by gamma irradiation or camptothecin treatment in prostate cancer cells and primary prostate epithelial cells [36].